Reduced Toxicity Conditioning for Hematopoietic Stem Cell Transplantation in Children with Diamond-Blackfan Anemia

Overview

Journal Haematologica

Specialty Hematology

Date 2024 May 30

PMID 38813735

Authors

Amr Qudeimat

Shruthi Suryaprakash

Renee Madden

Ashok Srinivasan

Marcin W Wlodarski

Senthil Velan Bhoopalan

Affiliations

Soon will be listed here.

References

Bhoopalan S, Wlodarski M, Reiss U, Triplett B, Sharma A . Reduced-intensity conditioning-based hematopoietic cell transplantation for dyskeratosis congenita: Single-center experience and literature review. Pediatr Blood Cancer. 2021; 68(10):e29177. DOI: 10.1002/pbc.29177. View

Bhoopalan S, Suryaprakash S, Sharma A, Wlodarski M . Hematopoietic cell transplantation and gene therapy for Diamond-Blackfan anemia: state of the art and science. Front Oncol. 2023; 13:1236038. PMC: 10518466. DOI: 10.3389/fonc.2023.1236038. View

Taher A, El Rassi F, Ismaeel H, Koussa S, Inati A, Cappellini M . Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia. Haematologica. 2008; 93(10):1584-6. DOI: 10.3324/haematol.13098. View

Miano M, Eikema D, de la Fuente J, Bosman P, Ghavamzadeh A, Smiers F . Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplant Cell Ther. 2021; 27(3):274.e1-274.e5. DOI: 10.1016/j.jtct.2020.12.024. View

Crazzolara R, Kropshofer G, Haas O, Matthes-Martin S, Kager L . Reduced-intensity conditioning and stem cell transplantation in infants with Diamond Blackfan anemia. Haematologica. 2016; 102(3):e73-e75. PMC: 5394961. DOI: 10.3324/haematol.2016.157149. View

Giri N, Kang E, Tisdale J, Follman D, Rivera M, Schwartz G . Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol. 2000; 108(1):167-75. DOI: 10.1046/j.1365-2141.2000.01796.x. View

Wang Y, Anderson E, Gloude N, Marion A, King C, Leung W . Irradiation-free RIC HSCT has a tolerable safety profile and is effective therapy for pediatric bone marrow failure syndromes. Pediatr Transplant. 2020; 25(2):e13855. DOI: 10.1111/petr.13855. View

Strahm B, Loewecke F, Niemeyer C, Albert M, Ansari M, Bader P . Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia. Blood Adv. 2020; 4(8):1760-1769. PMC: 7189291. DOI: 10.1182/bloodadvances.2019001210. View

Koyamaishi S, Kamio T, Kobayashi A, Sato T, Kudo K, Sasaki S . Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia. Bone Marrow Transplant. 2020; 56(5):1013-1020. DOI: 10.1038/s41409-020-01056-1. View

10.

de Wilde J, van Dooijeweert B, van Vuren A, Huisman E, Smiers F, van der Veer A . Transfusion burden in early childhood plays an important role in iron overload in Diamond-Blackfan anaemia. EJHaem. 2022; 3(4):1300-1304. PMC: 9713217. DOI: 10.1002/jha2.524. View

11.

Wlodarski M, Vlachos A, Farrar J, Da Costa L, Kattamis A, Dianzani I . Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement. Lancet Haematol. 2024; 11(5):e368-e382. DOI: 10.1016/S2352-3026(24)00063-2. View

12.

Bhoopalan S, Yen J, Mayuranathan T, Mayberry K, Yao Y, Lillo Osuna M . An RPS19-edited model for Diamond-Blackfan anemia reveals TP53-dependent impairment of hematopoietic stem cell activity. JCI Insight. 2022; 8(1). PMC: 9870085. DOI: 10.1172/jci.insight.161810. View

13.

Dahl M, Warsi S, Liu Y, Debnath S, Billing M, Siva K . Bone marrow transplantation without myeloablative conditioning in a mouse model for Diamond-Blackfan anemia corrects the disease phenotype. Exp Hematol. 2021; 99:44-53.e2. DOI: 10.1016/j.exphem.2021.06.002. View

14.

Burroughs L, Shimamura A, Talano J, Domm J, Baker K, Delaney C . Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. Biol Blood Marrow Transplant. 2017; 23(10):1669-1677. PMC: 5605451. DOI: 10.1016/j.bbmt.2017.06.002. View

15.

Diaz-de-Heredia C, Bresters D, Faulkner L, Yesilipek A, Strahm B, Miano M . Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT. Bone Marrow Transplant. 2021; 56(12):2956-2963. DOI: 10.1038/s41409-021-01449-w. View